HOME >> MEDICINE >> NEWS
Spinifex secures $3.25m investment to develop pain therapy

A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative new pain therapy.

Spinifex Pharmaceuticals, an emerging biotechnology company specialising in the development of therapeutics for the treatment of neuropathic pain, has attracted investment from a syndicate including Symbiosis Group Limited, Melbourne-based GBS Venture Partners Limited and Uniseed.

Spinifex Pharmaceutical Managing Director, Dr Michael Thurn said he was delighted by the investment commitment which will help to accelerate their drug development program.

"We've several promising small molecules currently under evaluation and we plan to be in a position to start a formal toxicology program on one of those molecules in 2006," said Dr Thurn.

"The two main causes of neuropathic pain are through diabetes, affecting an estimated 45 per cent of diabetics, and through complications arising from infection with herpes zoster [shingles], known as post-herpetic neuralgia.

"We see a significant world-wide market for our pain therapy, and this investment will progress our efforts in delivering a novel solution."

Spinifex's core technology relates to the discovery (made by University of Queensland researchers led by Professor Maree Smith) of a novel pathway for the treatment of neuropathic pain. Professor Smith's group successfully validated this pathway using small molecules in well-defined animal models of neuropathic pain.

Managing Director of investment company Symbiosis, Dr Mark Harvey, said Spinifex was an attractive investment, led by a strong team with extensive experience in the international and local biotechnology industry

He said the neuropathic pain market targeted by Spinifex's technology was currently valued at US$3 billion.

"With a solid intellectual property position and several 'drug-like' molecules already in hand we expe
'"/>

Contact: Dr Michael Thurn
61-7-3842-3153
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. University of Rochester spin-off secures $2 million in funding
2. Medical College of Wisconsin secures key contract from US HRSA
3. Molecular Profiling Institute secures $7.5 million in Series B funding
4. Menzies secures $1.8m in funding for the NT
5. ASU secures $3.9 million to study spinal cord injuries and neurological disorders
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. New PBS investment as PBS slows
8. Industry welcomes massive Victorian investment in medical research
9. European Science Foundation warns nanomedicine benefits will be lost without major investment
10. Medicares investment in quality improvement may not be paying off
11. Baby DVDs, videos may hinder, not help, infants language development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... MALVERN, Pa. (PRWEB) , ... May 21, 2020 ... ... Holdings, Inc. and an industry leader in cancer biomarker assays, announced today that ... coverage list. Cigna Corporation is a global health service company dedicated to improving ...
(Date:5/21/2020)... ... 2020 , ... ESO , the leading data and software company serving ... 2020 ESO Fire Service Index . The Index looks at key trends across ... turnout time and travel time, the most common property types visited and estimated property ...
(Date:5/17/2020)... ... May 18, 2020 , ... ... program at its Tijuana regenerative clinic. There are two program options for patients ... cell counts. , While it is unclear exactly what causes Autism Spectrum Disorder ...
(Date:5/15/2020)... ... , ... COVID-19 has made people feel fearful, but Rieke Office Interiors (ROI) ... get back to work safely. Their unique line of SafeSpace™ PPE equipment for the ... other settings. , Everyone needs to be able to get back to work and ...
(Date:5/15/2020)... ... May 15, 2020 , ... AdventHealth Tampa, ... atop the hospital’s new six-story, 300,000 square foot patient and surgical tower Friday, ... The topping off celebrates the structural completion of the $256 million project. Construction ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Murrieta Genomics has partnered with ... to offer startup companies a special discount rate to the Digital RESI 3-Day ... was created by LSN to bring together startups with early-stage investors and strategic channel ...
(Date:5/17/2020)... ... May 17, 2020 , ... CyberMaxx™ has ... by Insyte CPAs, LLC, an independent service auditor. This certification illustrates CyberMaxx's constant ... organizations can rely. , "It was a pleasure to work with the CyberMaxx ...
(Date:5/16/2020)... PASO ROBLES, Calif. (PRWEB) , ... May 16, 2020 , ... ... causes of mold damage in buildings starts with water damage. Atascadero SERVPRO ... of defense against mold. , Understanding the connection between water damage and mold gives ...
Breaking Medicine Technology:
Cached News: